Chapter 15: Local Anesthetics — Module 4: Toxicity, Adverse Effects, and Special Populations Tier: Foundational Recall (16 questions)
1. The systemic toxicity of local anesthetics on the heart and brain is mediated primarily through action on which molecular target?
A) Voltage-gated calcium channels exclusively, with no involvement of other ion channels
B) Beta-adrenergic receptors on cardiac myocytes
C) Voltage-gated sodium (Nav) channels, with additional contributions from potassium and calcium channel inhibition at high concentrations
D) Muscarinic acetylcholine receptors in the conduction system
E) The cardiac ryanodine receptor regulating sarcoplasmic calcium release
ANSWER: C
Rationale:
Local anesthetic systemic toxicity is mediated primarily by blockade of voltage-gated sodium (Nav) channels in cardiac and neural tissue — the same channel class responsible for the therapeutic conduction block. At the supraclinical concentrations seen in toxicity, additional inhibition of potassium and calcium channels and interference with intracellular calcium handling contribute to the cardiovascular picture, but Nav channel blockade is the central mechanism.
Option A: Option A is incorrect because calcium channel effects are contributory at high concentrations, not the exclusive or primary mechanism.
Option B: Option B is incorrect because local anesthetics do not act on beta-adrenergic receptors; that is the domain of catecholamines and beta-blockers.
Option D: Option D is incorrect because muscarinic receptors are not the target of local anesthetic toxicity.
Option E: Option E is incorrect because, although disordered calcium handling contributes, the ryanodine receptor is not the primary molecular target of local anesthetic action.
2. LAST arises by three distinct mechanisms: unintentional intravascular injection, absolute dose excess, and delayed accumulation. Which mechanism is most specifically associated with continuous peripheral nerve block catheter techniques?
A) Delayed accumulation, in which drug builds up over hours to days of infusion, particularly in patients with hepatic impairment or reduced protein binding
B) Unintentional intravascular injection producing an immediate bolus
C) Absolute dose excess delivered in a single injection
D) An IgE-mediated allergic mechanism releasing drug from tissue
E) Renal failure causing retention of the parent amide drug
ANSWER: A
Rationale:
Delayed accumulation is the mechanism increasingly recognized with continuous peripheral nerve block catheters, where drug is delivered over an extended period (typically 24 to 72 hours). Accumulation is more likely in patients with hepatic impairment, reduced protein binding, or high total delivery, and it produces a gradual rise rather than an abrupt spike.
Option B: Option B is incorrect because intravascular injection produces an immediate bolus, characteristic of single injections rather than the slow buildup of catheter infusions.
Option C: Option C is incorrect because absolute dose excess refers to a single oversized dose, not the gradual accumulation of an infusion.
Option D: Option D is incorrect because LAST is a dose-dependent pharmacologic toxicity, not an allergic mechanism.
Option E: Option E is incorrect because amide local anesthetics are cleared hepatically, so renal retention of parent drug is not the driver of accumulation toxicity.
3. The CNS manifestations of LAST follow a characteristic biphasic pattern of early excitation (agitation, muscle twitching, seizures) followed by depression (coma, apnea). What accounts for the early excitatory phase?
A) Local anesthetics directly stimulate excitatory glutamate receptors before any inhibitory effect occurs
B) The drug first increases cerebral blood flow, causing transient hyperactivity
C) Seizures release stored catecholamines that drive the excitation
D) Inhibitory cortical circuits are more sensitive and are depressed first, leaving excitatory pathways transiently unopposed before they too are suppressed
E) The excitation reflects a paradoxical allergic response in the brain
ANSWER: D
Rationale:
The early excitatory phase of LAST is explained by preferential depression of inhibitory cortical circuits at lower drug concentrations. With inhibition removed first, excitatory pathways operate unopposed, producing agitation, muscle twitching, and ultimately generalized tonic-clonic seizures. As concentrations rise further, the excitatory circuits are also suppressed, yielding global CNS depression with coma and apnea.
Option A: Option A is incorrect because the mechanism is disinhibition (loss of inhibitory tone), not direct stimulation of excitatory receptors.
Option B: Option B is incorrect because the excitatory phase reflects altered circuit balance, not a primary increase in cerebral blood flow.
Option C: Option C is incorrect because catecholamine release is not the explanation for the characteristic excitation-then-depression sequence.
Option E: Option E is incorrect because LAST is a dose-dependent toxic phenomenon, not an allergic one.
4. The lung first-pass effect plays an important protective role in modulating local anesthetic plasma levels. Which statement most precisely describes this role?
A) The lungs metabolize local anesthetics into inactive compounds during first pass
B) The lungs sequester and buffer lipid-soluble local anesthetic during gradual absorption, but this buffering is overwhelmed by a rapid intravascular bolus
C) The lungs excrete local anesthetics directly into the alveoli for exhalation
D) The lungs convert local anesthetics into more toxic metabolites on first pass
E) The lungs prevent any local anesthetic from reaching the systemic arterial circulation
ANSWER: B
Rationale:
The pulmonary circulation transiently sequesters and buffers lipid-soluble local anesthetic during the initial distribution phase, blunting the peak arterial concentration when drug is absorbed gradually. This buffering capacity is finite and is overwhelmed by a rapid intravascular bolus, which is one reason the rate of plasma rise — not just the peak concentration — determines toxicity severity.
Option A: Option A is incorrect because the lung effect is sequestration and buffering, not metabolic inactivation of the drug.
Option C: Option C is incorrect because local anesthetics are not eliminated by alveolar exhalation.
Option D: Option D is incorrect because the lung uptake buffers rather than bioactivates the drug into something more toxic.
Option E: Option E is incorrect because the lung buffering is partial and saturable, not an absolute barrier to systemic delivery.
5. When a large volume of long-acting local anesthetic is planned in a high-risk patient, agent selection can reduce cardiovascular risk. Which statement correctly discriminates the available long-acting amides?
A) Racemic bupivacaine has the lowest cardiotoxicity and is the preferred agent for large-volume blocks
B) All long-acting amides have identical cardiotoxicity, so agent choice does not affect cardiovascular risk
C) Lidocaine is longer-acting than bupivacaine and is preferred for prolonged blocks
D) Ropivacaine is more cardiotoxic than racemic bupivacaine for an equivalent analgesic dose
E) Ropivacaine and levobupivacaine carry a lower risk of cardiovascular collapse for a given analgesic dose than racemic bupivacaine, and are preferred when large volumes are needed
ANSWER: E
Rationale:
Ropivacaine and levobupivacaine carry a lower risk of cardiovascular collapse for a given analgesic dose than racemic bupivacaine, which is why they are preferentially chosen when large volumes of long-acting local anesthetic are planned, particularly in high-risk patients. This advantage reflects their reduced affinity for, and faster dissociation from, cardiac sodium channels relative to racemic bupivacaine.
Option A: Option A is incorrect because racemic bupivacaine is the most cardiotoxic of the group, not the least.
Option B: Option B is incorrect because the agents differ meaningfully in cardiotoxicity, so selection does matter.
Option C: Option C is incorrect because lidocaine is intermediate-acting, not longer-acting than bupivacaine, and is not the agent for prolonged blocks.
Option D: Option D is incorrect because it reverses the relationship; ropivacaine is less, not more, cardiotoxic than racemic bupivacaine.
6. Bupivacaine cardiotoxicity is particularly resistant to defibrillation and epinephrine. Which property of bupivacaine best explains this resistance?
A) Bupivacaine is rapidly metabolized in the myocardium, so toxic levels persist only briefly
B) Bupivacaine binds cardiac potassium channels selectively, sparing sodium channels
C) Bupivacaine binds cardiac sodium channels with fast-in, slow-out kinetics, so even after successful cardioversion the channels rapidly re-block, sustaining conduction failure
D) Bupivacaine has no effect on cardiac conduction and causes arrest purely through vasodilation
E) Bupivacaine dissociates from sodium channels faster than lidocaine does
ANSWER: C
Rationale:
Bupivacaine binds the cardiac Nav1.5 sodium channel with fast-in, slow-out kinetics — it enters quickly but dissociates very slowly during diastole. Consequently, even when electrical cardioversion briefly restores rhythm, the channels rapidly re-accumulate block, sustaining conduction failure and making the arrest resistant to defibrillation and to epinephrine. ECG manifestations progress from PR-interval and QRS-complex (the ventricular depolarization waveform, QRS) widening and QT prolongation to ventricular tachycardia and fibrillation.
Option A: Option A is incorrect because slow channel dissociation, not rapid myocardial metabolism, is the issue, and toxicity is persistent rather than brief.
Option B: Option B is incorrect because the defining mechanism is sodium channel block, not selective potassium channel binding.
Option D: Option D is incorrect because bupivacaine profoundly impairs cardiac conduction rather than acting purely through vasodilation.
Option E: Option E is incorrect because bupivacaine dissociates more slowly than lidocaine, not faster, which is precisely why it is more cardiotoxic.
7. According to the ASRA (American Society of Regional Anesthesia and Pain Medicine) protocol, what is the correct initial dosing of intravenous lipid emulsion (Intralipid 20%) for LAST in an adult?
A) A bolus of 1.5 mL/kg over 2 to 3 minutes, followed immediately by an infusion of 0.25 mL/kg/min
B) A bolus of 15 mL/kg over 30 seconds, with no subsequent infusion
C) A continuous infusion of 0.01 mL/kg/min with no bolus
D) A single 5 mL/kg bolus repeated every minute until 50 mL/kg is reached
E) A bolus of 0.15 mL/kg followed by an infusion of 2.5 mL/kg/min
ANSWER: A
Rationale:
The ASRA-recommended regimen begins with an intravenous bolus of lipid emulsion 20% at 1.5 mL/kg (roughly 100 mL in a 70 kg adult) given over 2 to 3 minutes, followed immediately by an infusion of 0.25 mL/kg/min. If hemodynamic stability is not achieved, the bolus may be repeated up to twice and the infusion rate doubled to 0.5 mL/kg/min, with an approximate upper limit near 10 to 12 mL/kg in the first 30 minutes.
Option B: Option B is incorrect because the bolus dose and rate are far too high and a maintenance infusion is required.
Option C: Option C is incorrect because the protocol requires an initial bolus and uses a substantially higher infusion rate.
Option D: Option D is incorrect because it describes an unsafe escalating bolus far exceeding the recommended total.
Option E: Option E is incorrect because the bolus is too small and the infusion rate is implausibly high relative to the protocol.
8. LAST-specific cardiac resuscitation differs from standard ACLS in several drug choices. Which statement correctly states one of these modifications?
A) Vasopressin is the preferred first-line vasopressor in LAST arrest
B) Standard 1 mg epinephrine boluses are preferred to maximize coronary perfusion
C) Amiodarone is the antiarrhythmic of choice for ventricular dysrhythmias in LAST
D) Amiodarone should be avoided because it adds further sodium and potassium channel blockade to an already-compromised conduction system
E) Calcium channel blockers should be given routinely to counteract sodium channel block
ANSWER: D
Rationale:
In LAST, amiodarone should be avoided for ventricular dysrhythmias because it adds further sodium and potassium channel blockade to a conduction system already poisoned by the local anesthetic, potentially worsening the arrhythmia. The recognized LAST modifications also include using reduced doses of epinephrine (10 to 100 micrograms rather than the standard 1 mg) and avoiding vasopressin.
Option A: Option A is incorrect because vasopressin is specifically not recommended in LAST-related arrest.
Option B: Option B is incorrect because large standard epinephrine doses can worsen arrhythmias in this setting, so reduced doses are advised.
Option C: Option C is incorrect because amiodarone is to be avoided, not chosen, in bupivacaine-related toxicity.
Option E: Option E is incorrect because routine calcium channel blockade is not part of LAST management and would not counteract the sodium channel block.
9. A patient is reported to have reacted to a multidose vial of an amide local anesthetic. Given that true amide allergy is extremely rare, which explanation most precisely accounts for many such apparent amide reactions?
A) Amide agents are metabolized to PABA, the same allergen produced by esters
B) Methylparaben, a preservative in multidose amide vials, is structurally similar to PABA and can trigger reactions in PABA-sensitive individuals
C) Amide agents always cross-react with ester agents at the receptor level
D) The reaction proves a genuine IgE-mediated amide allergy that contraindicates all local anesthetics
E) Amide agents spontaneously degrade into histamine within the vial
ANSWER: B
Rationale:
Many reactions attributed to amide agents are actually due to methylparaben, a preservative used in multidose amide vials whose structure resembles PABA; in PABA-sensitive individuals it can elicit a reaction even though the amide itself is not the culprit. The practical solution is to use single-dose, preservative-free amide formulations, which removes the preservative as a confounder.
Option A: Option A is incorrect because amide metabolism does not produce PABA; that is the ester pathway.
Option C: Option C is incorrect because esters and amides do not cross-react, as their allergenic chemistry differs.
Option D: Option D is incorrect because such reactions rarely represent true amide allergy and do not justify avoiding all local anesthetics.
Option E: Option E is incorrect because amides do not spontaneously degrade into histamine in the vial.
10. Methemoglobinemia impairs oxygen delivery by more than one mechanism. Which statement most precisely describes why it is disproportionately impairing relative to an equivalent drop in normal hemoglobin?
A) Methemoglobin binds oxygen more tightly but releases it normally, causing only mild impairment
B) Methemoglobin increases total oxygen-carrying capacity but slows circulation
C) Methemoglobin has no effect on the remaining normal hemoglobin and only reduces total count
D) Methemoglobin raises the oxygen tension in plasma, masking the deficit
E) Methemoglobin cannot carry oxygen (functional anemia) AND shifts the oxygen-hemoglobin dissociation curve of the remaining normal hemoglobin to the left, reducing oxygen release to tissues
ANSWER: E
Rationale:
Methemoglobinemia impairs oxygen delivery through two combined effects: the methemoglobin fraction cannot bind or transport oxygen (a functional anemia), and its presence shifts the oxygen-hemoglobin dissociation curve of the remaining normal hemoglobin to the left, so that hemoglobin holds oxygen more tightly and releases less to the tissues. This dual mechanism makes methemoglobinemia more impairing than an equivalent reduction in hemoglobin from simple anemia. Co-oximetry directly measures the methemoglobin fraction and is the diagnostic test of choice.
Option A: Option A is incorrect because methemoglobin cannot carry oxygen at all and the impairment is not mild.
Option B: Option B is incorrect because methemoglobin reduces, rather than increases, effective oxygen-carrying capacity.
Option C: Option C is incorrect because methemoglobin does affect the remaining hemoglobin by shifting its dissociation curve.
Option D: Option D is incorrect because methemoglobin does not raise plasma oxygen tension or mask the deficit.
11. Methylene blue both treats and, in excess, can worsen methemoglobinemia. Which statement correctly captures this dual nature?
A) Methylene blue works independently of NADPH and has no upper dose limit
B) Methylene blue is effective only in G6PD-deficient patients
C) Methylene blue is reduced via an NADPH-dependent system to accelerate conversion of methemoglobin back to functional hemoglobin, but is itself an oxidizing agent that can paradoxically worsen methemoglobinemia at excessive doses (above roughly 7 mg/kg)
D) Methylene blue acts by directly binding oxygen and delivering it to tissues
E) Methylene blue permanently inactivates the methemoglobin reductase enzyme
ANSWER: C
Rationale:
Methylene blue is reduced to leukomethylene blue using NADPH generated by the hexose monophosphate shunt; leukomethylene blue then donates electrons to accelerate the enzymatic reduction of methemoglobin (Fe3+) back to functional hemoglobin (Fe2+). However, methylene blue is itself an oxidizing agent, and at excessive doses (above approximately 7 mg/kg) it can paradoxically worsen methemoglobinemia — a reminder that careful dosing is essential.
Option A: Option A is incorrect because methylene blue requires NADPH for activation and does have a dose ceiling.
Option B: Option B is incorrect because it is ineffective in G6PD deficiency (which limits NADPH), the opposite of the claim.
Option D: Option D is incorrect because methylene blue does not itself carry and deliver oxygen.
Option E: Option E is incorrect because it accelerates rather than inactivates the reductase system.
12. Transient neurologic symptoms (TNS) and cauda equina syndrome (CES) are both neurologic complications of neuraxial local anesthesia. Which statement most precisely discriminates them?
A) TNS is self-limited pain or dysesthesia in the buttocks and lower extremities that resolves within about 72 hours without permanent deficit, whereas CES is true, permanent or partially reversible nerve-root injury producing saddle anesthesia and bowel or bladder dysfunction
B) TNS and CES are the same entity described by two different names
C) TNS causes permanent paralysis, while CES is a benign self-limited pain syndrome
D) CES resolves spontaneously within 72 hours, while TNS causes irreversible deficits
E) Both TNS and CES always produce permanent bowel and bladder dysfunction
ANSWER: A
Rationale:
TNS presents as pain or dysesthesias in the buttocks, posterior thighs, and lower extremities, beginning within 6 to 24 hours of spinal anesthesia and resolving spontaneously within about 72 hours with no permanent neurologic deficit. CES is a far more serious complication: true, permanent or only partially reversible injury to the cauda equina nerve roots, producing saddle anesthesia, bowel and bladder dysfunction, and lower extremity weakness. The key discriminator is reversibility and the presence of structural deficit.
Option B: Option B is incorrect because they are distinct entities with very different prognoses.
Option C: Option C is incorrect because it reverses the two; TNS is the benign self-limited one.
Option D: Option D is incorrect because it also reverses them; CES is the one with lasting deficits.
Option E: Option E is incorrect because TNS does not produce bowel or bladder dysfunction, which is a feature of CES.
13. The incidence of transient neurologic symptoms after spinal anesthesia varies markedly by agent and positioning. Which combination carries the highest reported incidence?
A) Preservative-free chloroprocaine in the supine position
B) Hyperbaric lidocaine 5% intrathecally, with the highest rates in the lithotomy position
C) Hyperbaric bupivacaine in the prone position
D) Ropivacaine for peripheral nerve block
E) Mepivacaine given by the epidural route
ANSWER: B
Rationale:
TNS incidence is highest with intrathecal hyperbaric lidocaine 5%, with reported rates ranging widely in published series and the highest rates occurring with the lithotomy position, which favors pooling of the dense lidocaine solution around the dependent sacral nerve roots. Incidence is substantially lower with hyperbaric bupivacaine, intermediate with mepivacaine, and near zero with preservative-free chloroprocaine.
Option A: Option A is incorrect because chloroprocaine is associated with a near-zero TNS rate, not the highest.
Option C: Option C is incorrect because hyperbaric bupivacaine carries a low TNS incidence.
Option D: Option D is incorrect because TNS is a neuraxial phenomenon and is not the characteristic risk of a peripheral ropivacaine block.
Option E: Option E is incorrect because mepivacaine carries an intermediate rate and the epidural route is not the classic high-risk TNS scenario, which is intrathecal lidocaine.
14. Term pregnancy alters local anesthetic risk through several physiologic changes. Which statement correctly pairs a change in pregnancy with its consequence for neuraxial dosing?
A) Increased plasma albumin raises protein binding, so higher doses are required
B) Reduced cardiac output slows systemic absorption, lowering peak concentrations
C) Expanded epidural space volume reduces the cephalad spread of a given dose, requiring larger doses
D) The engorged epidural venous plexus reduces subarachnoid and epidural space volume, increasing the cephalad spread of a given dose and mandating dose reduction
E) Increased protein binding lowers the free fraction, reducing toxicity at term
ANSWER: D
Rationale:
At term, aortocaval compression and elevated inferior vena cava pressure engorge the epidural venous plexus, which reduces the volume of the subarachnoid and epidural spaces. As a result, a given dose of local anesthetic spreads more cephalad than in the non-pregnant patient, so doses must be reduced to avoid an excessively high block. Reduced protein binding (from dilutional hypoproteinemia) further raises the free fraction and adds to risk.
Option A: Option A is incorrect because albumin falls in pregnancy, lowering protein binding rather than raising it.
Option B: Option B is incorrect because cardiac output increases in pregnancy, producing higher peak concentrations more rapidly.
Option C: Option C is incorrect because the neuraxial space volume is reduced, not expanded, increasing spread for a given dose.
Option E: Option E is incorrect because protein binding decreases, raising the free fraction and increasing toxicity.
15. Neonates handle amide local anesthetics differently from adults. Which statement correctly summarizes the neonatal pharmacokinetic profile and its dosing implication?
A) Neonates have mature hepatic enzymes and clear amides faster than adults, permitting higher infusion rates
B) Neonates have high alpha-1-acid glycoprotein levels, so protein binding is greater and free drug is lower than in adults
C) Neonatal amide half-life is shorter than in adults, so accumulation during infusion is unlikely
D) Neonatal hemoglobin is more resistant to oxidation, eliminating methemoglobinemia risk
E) Immature CYP3A4 and CYP1A2 activity and low alpha-1-acid glycoprotein prolong the half-life and raise the free fraction, so maximum doses and continuous infusion rates must be reduced and monitoring extended
ANSWER: E
Rationale:
In neonates, hepatic CYP3A4 and CYP1A2 activity is substantially reduced and reaches adult levels only by 3 to 12 months, prolonging amide half-life (lidocaine roughly 3 hours in neonates versus about 1.5 hours in adults) and increasing accumulation risk during infusion. Alpha-1-acid glycoprotein is approximately half of adult levels, reducing protein binding and raising the free fraction. Consequently, maximum per-kilogram doses are lower, continuous infusion rates must be reduced, and monitoring should be extended.
Option A: Option A is incorrect because neonatal hepatic enzymes are immature and clearance is slower, not faster.
Option B: Option B is incorrect because neonatal alpha-1-acid glycoprotein is low, so protein binding is reduced and free drug is higher.
Option C: Option C is incorrect because the neonatal half-life is longer, making accumulation more likely.
Option D: Option D is incorrect because fetal/neonatal hemoglobin is more susceptible to oxidation, increasing methemoglobinemia risk from benzocaine and prilocaine.
16. A patient with Child-Pugh class C cirrhosis requires local anesthesia. Which statement correctly discriminates how hepatic disease affects amide versus ester local anesthetics?
A) Amides depend on hepatic metabolism, so their clearance falls and doses should be reduced (commonly by 25 to 50% for repeated or continuous dosing) in advanced cirrhosis, whereas esters are hydrolyzed by plasma and tissue esterases and are not significantly affected by hepatic parenchymal disease
B) Esters depend on hepatic metabolism and must be dose-reduced, while amides are cleared by plasma esterases and are unaffected
C) Both amides and esters are cleared exclusively by the kidney, so hepatic disease has no effect on either
D) Amides are unaffected by hepatic disease because they are eliminated unchanged in bile
E) Hepatic disease increases amide clearance, so higher doses are required in cirrhosis
ANSWER: A
Rationale:
Amide local anesthetics depend on hepatic metabolism (CYP enzymes), so advanced cirrhosis reduces their clearance, prolongs half-life, and — compounded by reduced albumin and alpha-1-acid glycoprotein raising the free fraction — increases toxicity risk; amide doses are commonly reduced by 25 to 50% for any repeated or continuous technique in Child-Pugh class B or C disease. Ester agents are hydrolyzed by plasma pseudocholinesterase and tissue esterases rather than hepatic CYP enzymes, so they are not significantly affected by hepatic parenchymal disease.
Option B: Option B is incorrect because it reverses the two classes; amides, not esters, are the hepatically cleared group.
Option C: Option C is incorrect because neither class is cleared exclusively renally, and hepatic disease clearly affects amides.
Option D: Option D is incorrect because amides are metabolized hepatically rather than eliminated unchanged in bile, and they are affected by hepatic disease.
Option E: Option E is incorrect because hepatic disease reduces, not increases, amide clearance, so doses should be lowered.
This Web-based pharmacology and disease-based integrated teaching site is based on reference materials that are believed reliable and consistent with standards accepted at the time of development.
Possibility of error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete.
Users should confirm the information contained herein with other sources.
This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site.
Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals.
Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.
Medical or other information thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.